VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1068008
Sex: F
Age:
State: IL

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Sore arm; body aches; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL1283; expiry date: unknown) via an unspecified route of administration in the left arm, on 25Jan2021 at 15:15, at a single dose, for COVID-19 immunization. The patient had no relevant medical history. Concomitant medication was not reported. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the workplace clinic. On 26Jan2021, at 04:00 AM, the patient experienced sore arm and body aches. The events were considered non-serious. The patient did not receive therapy for the events. Outcome of the events was unknown. The patient has not been tested for COVID-19 since vaccination.

Other Meds:

Current Illness:

ID: 1068009
Sex: F
Age:
State: WA

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: some soreness in left arm; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9261), via an unspecified route of administration on 25Jan2021 at 13:45 at a single dose on the left arm for COVID-19 immunization. Medical history included high blood pressure and a-fib (atrial fibrillation) both from an unknown date and unknown if ongoing. Prior to vaccination, the patient has not been diagnosed with COVID-19. Concomitant medication included lisinopril (LISINOPRIL), amlodipine (AMLODIPINE), atenolol (ATENOLOL), apixaban (ELIQUIS). Since the vaccination, the patient has not been tested for COVID-19. It was reported that the patient experienced some soreness in left arm next day, 26Jan2021. The patient did not receive any treatment for the event. The outcome of the event was recovered. The event was reported as non-serious.

Other Meds: LISINOPRIL; AMLODIPINE; ATENOLOL; ELIQUIS

Current Illness:

ID: 1068010
Sex: F
Age:
State: PA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also pruritis on back abdomen arms and legs.; diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also pruritis on back abdomen arms and legs.; Mild scratchy throat; This is a spontaneous report from a contactable nurse (patient). A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL3249), via an unspecified route of administration on 29Jan2021 13:15 at single dose (right arm) for COVID-19 immunization. Medical history included occasional gastric reflux and allergies. The patient was not pregnant. Patient had unspecified concomitant medications which was received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Jan2021, at 20:00, the patient developed a diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also, pruritis on back abdomen arms and legs and mild scratchy throat. The patient noticed these symptoms several hours after injection and was worse on day 2. There was no treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of events was not recovered.

Other Meds:

Current Illness:

ID: 1068011
Sex: F
Age:
State: CA

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Cough; This is a spontaneous report from a consumer (patient). A 94-year-old female (also the age at vaccination) patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number not reported), via an unspecified route of administration in the right arm on 26Jan2021 12:00 PM at SINGLE DOSE for COVID-19 immunization. The patient is vaccinated at a public health department. The patient is not pregnant. No other vaccines in four weeks. No COVID prior to vaccination and not COVID tested post vaccination. Medical history included High blood pressure, High Cholesterol both from unknown and if ongoing. Concomitant medication included amlodipine and simvastatin (reported as other medications in two weeks). It was reported that the patient experienced cough on 27Jan2021 at 12:00 PM. No treatment was given. The outcome of the event was not recovered. Information about Batch/Lot number has been requested

Other Meds: AMLODIPINE; SIMVASTATIN

Current Illness:

ID: 1068012
Sex: F
Age:
State: MN

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: body aches/body aches and especially the throbbing in head became much worse by midday/achy; slight throbbing in head/throbbing in head became much worse by midday; very tired; body chills and hot sweats on and off; body chills and hot sweats on and off; still lethargic and achy but improving; slept all day, and all night; eye pain which was triggered by light and eye movements; eye pain which was triggered by light and eye movements; This is a spontaneous report received from a contactable nurse (who is also the patient). A 46-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262, expiry date: unknown), via an unspecified route of administration on the left arm, on 29Jan2021 11:15, at single dose, for COVID-19 immunization, at an urgent care center. There was no medical history. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medication included probiotics. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date: unknown) received at age 46 years, via an unspecified route of administration on the left arm, on 08Jan2021 11:15, for COVID-19 immunization. On 30Jan2021 at 07:00, the patient experienced body aches and slight throbbing in head which became worse by midday; was very tired; returned to bed within 30 minutes and slept all day, and all night; had eye pain which was triggered by light and eye movements; body chills and hot sweats of and off. The patient reported that although she never had a fever according to her non contact forehead thermometer, she had body chills and hot sweats on and off. 48 hours later, she was still lethargic and achy but improving. Treatment for the events included ibuprofen 600 mg every 4-5 hours which helped but did not completely relieve the discomforts. The patient was recovering from the events.

Other Meds: PROBIOTICS

Current Illness:

ID: 1068013
Sex: F
Age:
State: KY

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Extreme muscle aches; fever; chills; headache; vomiting; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm on 29Jan2021 17:15 (at the age of 42-years-old) at single dose for COVID-19 immunization in the workplace clinic. Medical history included endometriosis, acid reflux, and history of blood clots. The patient had no known allergies. The patient was not pregnant. The patient did not have COVID prior to vaccination. Concomitant medication included methyldopa hydrochloride (ALDOMET [METHYLDOPA HYDROCHLORIDE]), omeprazole (PROTONIX [OMEPRAZOLE]), probiotics (PROBIOTICS), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and vitamins. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in the left arm on 08Jan2021 at 06:15 PM (at the age of 42-years-old) for COVID-19 immunization. The patient did not receive other vaccines in four weeks. The patient experienced extreme muscle aches, fever, chills, headache, vomiting on 30Jan2021 at 11:00 AM. The patient did not receive treatment for the events. The patient was not tested for COVID post vaccination. The outcome of the events was recovered in Jan2021. Information on the Lot/Batch number has been requested.

Other Meds: ALDOMET [METHYLDOPA HYDROCHLORIDE]; PROTONIX [OMEPRAZOLE]; PROBIOTICS; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1068014
Sex: F
Age:
State: OK

Vax Date: 01/11/2021
Onset Date: 01/19/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Right Lymph node breast swelling; This is a spontaneous report from a contactable healthcare professional (patient). A 34-year-old female patient received first single dose of BNT162B2 (Pfizer, Solution for injection, lot number: EL1283, exp date not reported), via an unspecified route of administration (vaccine location: right arm) on 11Jan2021 for COVID-19 immunization. Facility Type Vaccine: Hospital. The patient had no relevant history and had no known allergies. The patient was not pregnant at the time of vaccination and at the time of reporting. The patient did not have Covid prior vaccination. There was no other vaccine given within four weeks; and no other medications given within two weeks. On 19Jan2021 09:00 AM, the patient experienced right lymph node breast swelling. No treatment was given for the adverse event. The patient was not Covid tested post vaccination. The patient recovered from the event on an unspecified date in 2021.

Other Meds:

Current Illness:

ID: 1068015
Sex: M
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: chills; aches; malaise; headache; tingling in right arm for about 3-4 minutes/ vaccine location=Right arm; This is a spontaneous report from a contactable nurse. An adult male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), intramuscular on 08Jan2021 at a single dose in right arm for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no known allergies. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899) on 18Dec2020 at a single dose for COVID-19 immunization. About 12.5 hours after patient received the second dose (Lot EL1284) on 08Jan2021, he had tingling in right arm for about 3-4 minutes. When he went to work that next morning (09Jan2021) he started to develop chills, aches, malaise, and a headache around 0930/1000, about 24 hours after receiving the second dose. He did not become febrile at all after receiving the second the dose. The chills, aches, and malaise resolved within six hours after taking some Ibuprofen. The headache lasted for the next two days, with the worst of it being that Sunday (10Jan2021). It resolved the next day. Therapeutic measures were taken as a result of the events chills, aches, malaise, and headache which included ibuprofen. No treatment for vaccination site paresthesia. The outcome of the events was recovered on Jan2021. Facility type Vaccine was Hospital. No other vaccine in four weeks. Not diagnosed with COVID prior vaccination. COVID tested post vaccination with Nasal Swab, covid test result is Negative.

Other Meds:

Current Illness:

ID: 1068016
Sex: F
Age:
State:

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: COPD; osteoarthritis; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 30Jan2021 at SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced chronic obstructive pulmonary disease (COPD) and osteoarthritis which she takes 800 mg ibuprofen and inhaler as treatment. Furthermore, an antibiotic doxycycline. Asking if she should reduce medications. Therapeutic measures were taken as a result of COPD and osteoarthritis. The outcome of all the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068017
Sex: F
Age:
State: UT

Vax Date: 01/29/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Filler swelling (face); This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El9265, expiry date: unknown), via an unspecified route of administration on the left arm, on 29Jan2021 17:00, at single dose, for covid-19 immunization, at a public health department. Medical history included hypothyroidism. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. The patient's concomitant medications were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiry date: unknown) received at 41 years of age, via an unspecified route of administration on the right arm, on 08Jan2021 17:00, for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. On 31Jan2021, the patient experienced filler swelling (face) (pending clarification). It was unknown if treatment was received for the event. The outcome of the event was not recovered. The reporter assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 1068018
Sex: M
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: swollen glands left side only; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number ej1686 and expiry date unknown, via unspecified route of administration at the left arm on 11Jan2021 12:00 PM at single dose for Covid-19 immunization in a hospital. Medical history was none. The patient's concomitant medications were not reported. The patient has no other medications received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Jan2021 12:00 PM, the patient experienced swollen glands left side only. The patient has not been tested for COVID-19 since vaccination. The patient did not received treatment due to the events. The outcome of the event was recovering. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1068019
Sex: F
Age:
State: MO

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: I experienced sharp pain laterally through my deltoid muscle; ached/painful/ douloureux; Higher than normal blood sugar; This is a spontaneous report from a contactable consumer (patient herself). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not provided), via an unspecified route of administration in left arm on 27Jan2021 14:00 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. She had no allergies to medications, food, or other products. She was not pregnant. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. The patient stated "I experienced sharp pain laterally through my deltoid muscle, ached/painful, and higher than normal blood sugar" on 27Jan2021 14:30. The events were reported as non-serious and no treatment was received. The outcome of the events was recovering. The patient had not been tested for COVID-19 since the vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068020
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: skin on head started to feel itchy; urticaria on her body; some rash on the area on front of both thighs; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on the left arm, on 11Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After 3 days since he vaccination, on Jan2021, patient's skin on head started to feel itchy, and it lasted for so many days, and recently her body feels itchy too. After that she checked her body and found urticaria on her body, under arm pit of both armpit, vaccination side was on her left side, on her belly in some areas, and there was also some rash on the area on front of both thighs. There was also in her head, beneath her hair. Patient had never had before the Covid vaccine and was still experiencing those effects. Outcome of the events was unknown. Patient was due to go back 08Feb2020 of the second dose No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1068021
Sex: M
Age:
State: AZ

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: fatigue/tiredness on second day after shot; This is a spontaneous report from a contactable consumer (patient). A 90-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration at right arm on 30Jan2021 10:45 at single dose for COVID-19 immunization. Medical history included Congestive heart failure (CHF). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. On 31Jan2021 13:00, the patient experienced fatigue/tiredness on second day after shot. No treatment was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068022
Sex: M
Age:
State: NJ

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Light fever; sore throat; chills; feeling unwell; tiredness; Sleepy; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration at the left arm on 28Jan2021 16:45 at single dose for COVID-19 immunization. Medical history included open heart surgery and being diabetic. Concomitant medication included metformin, sitagliptin (JANUVIA), acetylsalicylic acid (ASPRIN), atorvastatin, and fenofibrate (TRICOR). The patient previously took moxifloxacin (AVELOX), levofloxaxin (LEVAQUIN), ciprofloxacin (CIPRO), and cloxacillin sodium (LOXACIN) and experienced allergies. The patient experienced light fever, sore throat, chills, feeling unwell, tiredness, and sleepy on 28Jan2021 16:45. The patient did not receive treatment for the events. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds: METFORMIN; JANUVIA; ASPRIN; ATORVASTATIN; TRICOR

Current Illness:

ID: 1068023
Sex: F
Age:
State:

Vax Date: 12/25/2020
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: tingling; throbbing; pressure on the top and back of her head; This is a spontaneous report from a contactable nurse (patient). A female patient of unspecified age (39, age unit unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection; lot and expiry were not reported), via an unspecified route of administration on 25Dec2020 at single dose for COVID-19 immunization. The patient's medical history were not reported. Concomitant medication included paracetamol (TYLENOL) as prophylaxis on 25Dec2020. The patient called to report her side effects after receiving the Covid vaccine. She received the first dose of the Covid vaccine on 25Dec2020, in which she prophylactically took 1000 mg of paracetamol. The patient reported tingling, throbbing, and pressure on the top and back of her head on unspecified dates. The patient stated that this feeling would subside and then come back. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds: TYLENOL

Current Illness:

ID: 1068024
Sex: F
Age:
State: WA

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: feel a cold sensation in my groin and in my upper thighs; This is a spontaneous report from a contactable consumer. A 66-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration at right arm on 31Jan2021 09:45 at a single dose for COVID-19 immunisation. Medical history included liver damage from hepatitis C. Concomitant medications were not reported. On 31Jan2021, the patient reported that she felt fine and walked back to her vehicle. As she began to drive home (after an additional 5 minutes), the patient began to feel a cold sensation in her groin and in her upper thighs. It continued for about 1/2 hour and then subsided. No treatment was received. The outcome of the event was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068025
Sex: M
Age:
State: KY

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Higher than normal blood sugar; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), via an unspecified route of administration on 31Jan2021 08:30 (at 64-year-old) at single dose for COVID-19 immunization. Medical history included Type 2 diabetes. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication was not reported. Patient received Diabetes medication within 2 weeks of vaccination. The patient previously took Percocet and Bactrim, and experienced drug allergy for both. The patient experienced higher than normal blood sugar on 31Jan2021 10:30. Therapeutic measures were taken as a result of higher than normal blood sugar, patient took extra insulin. The outcome of the event was recovering. Event was reported as non-serious.

Other Meds:

Current Illness:

ID: 1068026
Sex: F
Age:
State:

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: extreme stomach cramps; vomiting; dizzy; headache; chills; This is a spontaneous report from a non-contactable other health professional (patient). A 30-year-old female non-pregnant patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number EL3302 and expiry date unknown, via unspecified route of administration on 28Jan2021 14:30 at single dose for Covid-19 immunization in a workplace clinic. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior vaccination. Historical vaccine included first dose of BNT162B2 lot number EL1284 on 01Jan2021 for Covid-19 immunization. The patient received other vaccines within 4 weeks prior to the COVID vaccine. On 29Jan2021, the patient experienced extreme stomach cramps, vomiting, dizzy, headache, chills. The patient did not received treatment for the adverse events. The patient has not been tested for COVID-19 since vaccination. The outcome of the events was recovering. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1068027
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: shortness of breath, tingling feeling in lip and face; shortness of breath, tingling feeling in lip and face; shortness of breath, tingling feeling in lip and face; This is a spontaneous report from a contactable other healthcare professional (HCP) who reported for herself. A 61-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) intramuscularly on 20Jan2021 at 14:45 (at the age of 61-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included restless leg syndrome from an unspecified date and unspecified if ongoing. It was unknown whether the patient was diagnosed with COVID-19 prior to vaccination. Concomitant medications (received within 2 weeks of vaccination) included tretinoin (RETIN A; skin cream), biotin, vitamin D NOS, calcium and multivitamin, all taken for unspecified indications on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced shortness of breath, tingling feeling in lip and face, all on 20Jan2021, all reported as non-serious. The events did not cause hospitalization. No treatment was received for the events. The clinical outcomes of the events shortness of breath, tingling feeling in lip and face were all unknown. It was also reported that since the vaccination the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: RETIN A; BIOTIN; VITAMIN D NOS; CALCIUM

Current Illness:

ID: 1068028
Sex: M
Age:
State: NJ

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Nasal congestion; sore throat; This is a spontaneous report from a contactable consumer (reported for himself). A 42-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 29Jan2021 08:30 at a single dose in the left arm for covid-19 immunization. Medical history included diabetic and traumatic brain injury, both from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Jan2021, the patient experienced nasal congestion and sore throat. No treatment received for the adverse events reported. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, the patient had not been tested for COVID-19. The events were reported as not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068029
Sex: F
Age:
State: VA

Vax Date: 01/12/2021
Onset Date: 01/15/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: sore arm; diarrhea; sore rib; lump on neck; This is a spontaneous report from a contactable consumer. A 29-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; Lot number: Ek4176), via an unspecified route of administration in the left arm on 12Jan2021 at 16:45 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, PCOS (polycystic ovaries), and allergy to penicillin. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine, was not diagnosed with COVID-19 prior to vaccination, and was not pregnant at the time of vaccination. Concomitant medications included levothyroxine, metformin, and daily multivitamins (also reported as medication that the patient received within two weeks of vaccination). After the first dose, on 15Jan2021, the patient experienced sore arm, diarrhea starting day 3 through today, sore rib, and lump on neck. It was unknown if the events were treated. It was reported that the events resulted in a doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).

Other Meds: LEVOTHYROXINE; METFORMIN

Current Illness:

ID: 1068030
Sex: F
Age:
State:

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: rash on legs, arms, chest and stomach; headache; fever; chills; body ache; 3 days with out sleeping; This is a spontaneous report from a non-contactable consumer (patient herself) via Medical Information team. A 70-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL8982, expiration date was unknown), via an unspecified route of administration on 14Jan2021 at a single dose for COVID-19 immunization. Relevant medical history included anaphylaxis with insect bites from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took codeine and diazepam (VALIUM) and experienced hyperkinetic reaction. The patient stated that she received the vaccine on 14Jan2021, and that day 6 hours later, she had headache, fever, chills and body ache; and the next day on 15Jan2021, when she woke up, she had rash on legs, arms, chest and stomach, and she still had the rash. On an unspecified date, the patient had 3 days with out sleeping. The patient assessed the events as non-serious. The patient further reported that she was hyperkinetic and she has had that reaction many years prior reporting, before when taking codeine or VALIUM, one of the ingredients in VALIUM. She went to the doctor the first day, who saw her rash and told her to report that. It was not itching. The patient had the appointment for the second dose of the Pfizer vaccine, this coming Thursday and wanted to know if there would be a problem to get the second dose. She was afraid to get the vaccine the first time, because she had a history of anaphylaxis with insect bites. She carried an epi pen, and the vaccine provider had one too and the paramedics was there, and everything was okay; they were nice with her. The patient didn't have any problem until later. The patient spoke to her health care professional and he thought it was okay for her to get the second dose and the health care professional just told her to put a cream on her rash. Therapeutic measures were taken as a result of rash on legs, arms, chest and stomach, which included putting a cream on her rash. The patient was not recovered from the rash on legs, arms, chest and stomach, while the outcome of the events "headache, fever, chills, body ache, and 3 days with out sleeping" was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1068031
Sex: F
Age:
State: CO

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: shaking chills (rigor) 12H post shot; muscle aches; headache; fatigue (slept all next day); brain fog; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: el3247 and expiry date: unknown), via an unspecified route of administration on 28Jan2021 10:45 at a single dose for COVID-19 immunization. Medical history included mild asthma and mild hypertension. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to covid vaccine and had unspecified medications within 2 weeks. The patient experienced shaking chills (rigor) 12H post shot, lasted 3 hrs; also has muscle aches, headache (3days), fatigue (slept all next day), brain fog on 28Jan2021 23:00. Outcome of the events was recovering. Patient took ibuprofen 36 hours after shot as treatment for the adverse events. The reporter considered the events non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.

Other Meds:

Current Illness:

ID: 1068032
Sex: F
Age:
State: PA

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Severe injection site swelling (grapefruit size); Nose bleed; Fever of 102; Lethargy; Tachycardia; Shortness of Breath; Severe joint pain; Migraine; Muscle pain; This is a spontaneous report from a contactable other healthcare professional (HCP reporting for self). A 26-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 27Jan2021 11:30 at a single dose in the right arm for COVID-19 immunization. Other medical history and known allergies were reported as none. The patient had no COVID prior vaccination. The patient was not pregnant at the time of the report and vaccination. Concomitant medications included zinc, ascorbic acid (VIT C), ergocalciferol (VIT D) and an unspecified birth control medication. The first dose of BNT162B2 (brand: Pfizer as reported) was received on 06Jan2021 12:00 PM in the left arm for COVID-19 immunization. The patient had no other vaccine in the four weeks prior to second dose vaccination. On 27Jan2021 23:00, the patient experienced nose bleed, fever of 102, severe injection site swelling (grapefruit size), lethargy, tachycardia, shortness of breath, severe joint pain, migraine and muscle pain. The patient did not receive treatments for the reported adverse events. Patient had COVID test post vaccination specified as nasal swab on 27Jan2021 with test result as negative. The events were reported as recovered with lasting effects. Information on the Lot/Batch number has been requested.; Sender's Comments: Considering the close drug-event temporal association and the location, the reasonable possibility that the reported severe injection site swelling is related to BNT162B2 seems likely.

Other Meds: ZINC; VIT C; VIT D

Current Illness:

ID: 1068033
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: a rash all over [her] body; A swelling face; Being tired; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, batch/lot number and expiry date unknown), via an unspecified route of administration on Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medication included diphenhydramine hydrochloride (BENADRYL). The patient experienced a rash all over her body, a swelling face, and being tired on an unspecified date after receiving the first dose of the COVID-19 vaccine. She said that her throat was ok, hadn't itch and she doesn't have a fever. The outcome of the events was unknown. Information about batch/lot number has been requested.

Other Meds: BENADRYL

Current Illness:

ID: 1068034
Sex: M
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: I had some pretty bad flu like symptoms/Began to have flu like symptoms, pretty severe flu like symptoms; pain; This is a spontaneous report from a contactable nurse (patient). A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) solution for injection, via an unspecified route of administration on 08Jan2021 (first dose, lot/batch number: EL1284, expiry date: Apr2021) at a single dose, then via an unspecified route of administration on 29Jan2021 (second dose, lot/batch number: EL1284 , expiry date: Apr2021) at a single dose for Covid-19 immunization. Medical history included was reported as none. There were no concomitant medications. Patient received his first vaccine on the 8th of this month and the second dose the 29th of this month. On both occasions for 3 days after the vaccine, he had some pretty bad flu like symptoms. He began to have flu like symptoms, pretty severe flu like symptoms and pain on 09Jan2021. He stated taking some Ibuprofen 400mg, every 8 hours as needed for pain. Outcome of the event flu like symptoms was not recovered while pain was unknown at the time of the report. No follow-up activities are needed. No further information is expected. Information regarding the lot/batch number has been obtained.

Other Meds:

Current Illness:

ID: 1068035
Sex: F
Age:
State: TX

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: think they might have been exposed to COVID-19 after receiving the vaccine; slight headache; a little bit of fever; little of bit of cold; chills; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 22Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient and her husband were near to a person who was diagnosed with COVID-19; but they haven't been tested for COVID-19, they think they might have been exposed to COVID-19 after receiving the vaccine. She asked if they would test positive for COVID-19 after the exposure and if that was the case, would their doctor defer or re-schedule their second dose which was currently scheduled for 15Feb2021. On an unspecified date after getting first dose of the COVID-19 vaccine, the patient experienced a slight headache and a little bit of fever, little of bit of cold and chills. The outcome of the event "think they might have been exposed to COVID-19 after receiving the vaccine" was unknown while the outcome of all other events was recovered on an unspecified date. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1068036
Sex: M
Age:
State: MA

Vax Date: 01/26/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Anxiety; tiredness; headache; chills; nausea; feeling unwell; This is a spontaneous report from a contactable healthcare professional (patient). A 71-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) solution for injection, intramuscular on right arm on 26Jan2021 at 10:30 AM at single dose for COVID-19 immunization. Medical history included chronic back pain. The patient has no allergies to medications, food, or other products. Concomitant medications included unspecified blood pressure and pain medications which he received within 2 weeks of vaccination. The patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), intramuscular at left arm on 05Jan2021 at 2:00 PM at single dose for COVID-19 immunization and experienced headaches for a week. The patient received his most recent COVID-19 vaccine at a hospital. He did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. On 28Jan2021 at 06:00 AM, the patient experienced anxiety, tiredness, headache, chills, nausea, and feeling unwell. All these feelings come and go but made him very uncomfortable. He was told that it would dissipate in 48 hours. There was no treatment received in response to the events. The outcome of the events was not recovered. The events were assessed as non-serious.

Other Meds:

Current Illness:

ID: 1068037
Sex: F
Age:
State: IL

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: left arm completely numb; tingling; This is a spontaneous report from a contactable other health professional (patient). A 34-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number EL1284 and expiry date unknown, via unspecified route of administration at the left arm on 30Dec2020 12:30 at single dose for Covid-19 immunization in a workplace clinic. Medical history included sinusitis, placenta precreta, infertility, C-section, sulfa allergy, seasonal allergy. The patient's concomitant medications were not reported. The patient previously took hydrocodone, coriander oil; both experienced allergies. The patient had no other vaccine in four weeks. On 31Dec2020 06:00, the patient experienced left arm completely numb and tingling for 4 weeks. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received treatment due to the events. The patient underwent lab tests and procedures which included nasal swab (Covid-19): negative on 26Jan2021. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1068038
Sex: M
Age:
State:

Vax Date: 01/24/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Body aches; headache; fatigue; This is a spontaneous report from a non-contactable other health professional reporting for himself. A 32-year-old male patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, Lot# el9263), via an unspecified route of administration in the left arm, on 24Jan2021, at single dose, for COVID-19 immunisation. Medical history included penicillin allergy. The patient was not diagnosed with COVID-19 prior to vaccination. There were no concomitant medications. Patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced body aches, headache and fatigue all on 31Jan2021 at 15:30 with outcome of not recovered. No therapeutic measures were taken as a result of the events. Since vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1068039
Sex: M
Age:
State: CA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Very achy for next 2 days; triggered what I believe could be a very bad sciatica situation; Both legs ache, sitting feels like cuts off circulation, standing hurts less but hurts. Leaning forward front of legs hurt, standing flat, back of legs hurt; Have not been able to sleep for last 3 days due to the pain; This is a spontaneous report from a contactable consumer who reported for himself, a 65-year-old male patient who received the first fose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm, on 28Jan2021 at 15:30, at the age of 65 years, at a single dose for COVID-19 immunization. There were no medical history and no concomitant medications. The patient had no known allergies. Patient was very achy for next 2 days, that seems consistent with all he have read. Reaction to vaccine has transitioned to or triggered what he believe could be a very bad sciatica situation. Both legs ache, sitting feels like cuts off circulation, standing hurts less but hurts. Leaning forward front of legs hurt, standing flat, back of legs hurt. Have not been able to sleep for last 3 days due to the pain. Tried lying on back, side, with pillows under legs, on floor with legs up on a chair. Have never had sciatica issue before. Patient experienced all reported events on 28Jan2021 at 19:30. The patient asked what can be done to eliminate the pain. Patient had no COVID prior vaccination, and was not COVID tested post vaccination. No treatment was received for the events. The outcome of the events was not recovered. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1068040
Sex: F
Age:
State: OH

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Bright red rash; large welts covering across butt; purple in spots; Chills; fatigue; Loss appetite; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient received first single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and expiration date not reported), via an unspecified route of administration (vaccine location: left arm) on 27Jan2021 10:00 for COVID-19 immunization. Facility type Vaccine: Pharmacy/Drug Store. Medical history included high blood pressure and heart surgery in past. The patient was not pregnant at the time of vaccination and at the time of reporting. The patient had no known allergies. The patient had no Covid prior vaccination. Concomitant medications/ other medications included metoprolol, rosuvastatin, and OTC anti acid. There was no other vaccine given withiin four weeks. On 27Jan2021 23:00, the patient experienced chills, fatigue and loss appetite; bright red rash and large welts covering across butt - needed to seek treatment at urgent care. It was now 4 days later and still present and purple in spots. Prescription cream (unspecified) was given. The outcome of events was not recovered. Information on the lot/batch number has been requested.

Other Meds: METOPROLOL; ROSUVASTATIN

Current Illness:

ID: 1068041
Sex: F
Age:
State: MI

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Severe headache; Nausea; Myalgia; sore/itchy throat; Sore/itchy throat; Fever and chills within 3-4 post vaccination; Fever and chills within 3-4 post vaccination; This is a spontaneous report from a contactable healthcare professional who reported for herself, a 21-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), intramuscular in the right arm, on 30Jan2021 at 18:30, at the age of 21 years, at a single dose for COVID-19 immunization. Medical history included asthma, and known allergies to azithromycin (ZITHROMAX) and sulfa. The patient was not pregnant, and not pregnant at time of vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. On 30Jan2021 at 21:30, the patient experienced fever and chills within 3-4 post vaccination. The patient experienced severe headache, nausea, myalgia, and sore/itchy throat the next day, on 31Jan2021. No treatment was received for the events. Patient had no COVID prior vaccination, and was not COVID tested post vaccination. The outcome of the events was recovering. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1068042
Sex: F
Age:
State:

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Headaches; Chills/shivering; Nauseated; Body aches; This is a spontaneous report from a contactable consumer (patient) reported that a 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Jan2021 11:00 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. After dinner of 30Jan2021, the patient started having symptoms listed as headaches, chills, nauseated, and body aches. She described her chills as being so bad that she woke up last night shivering. She said the nausea and body aches come and go. She asked how long will her symptoms last. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068043
Sex: F
Age:
State: CA

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Severe body aches and headaches 12 hours after administration of 2nd dose.; Severe body aches and headaches 12 hours after administration of 2nd dose.; First dose's administration date 13Jan2021, second dose's administration date: 30Jan2021; First dose's administration date 13Jan2021, second dose's administration date: 30Jan2021; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9262, expiry date: not reported), via an unspecified route of administration at left arm on 30Jan2021 at SINGLE DOSE for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history included polycystic ovary syndrome (PCOS), gilbert's syndrome, bipolar disorder, and allergies to sulfa. The patient received unspecified concomitant medication received within 2 weeks of vaccination. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL1283), at left arm on 13Jan2021 at 06:30 PM for COVID-19 Immunisation. On 31Jan2021 at 04:30 AM, the patient experienced severe body aches and headaches 12 hours after administration of 2nd dose. The reporter considered the events non-serious. There was no treatment received for the events. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The outcome of the events severe body aches and headaches was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1068044
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Runny nose; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included citalopram hydrobromide (CELEXA). The patient experienced runny nose on 29Jan2021 08:00. No therapeutic measure was taken as a result of the event. Clinical outcome of the event was recovering. Information on the lot/batch number has been requested.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]

Current Illness:

ID: 1068045
Sex: F
Age:
State: AZ

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: the injection site is still slightly pink and itches several times a day/ it was a little tender to touch; the injection site is still slightly pink and itches several times a day/ it was a little tender to touch; the injection site is still slightly pink and itches several times a day/ it was a little tender to touch; This is a spontaneous report from a contactable consumer (reporting for herself). A 68-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EL 1284, expiration date unknown) via an unspecified route of administration in the left arm on 17Jan2021 19:00 (at 68 years old) at a SINGLE DOSE for COVID-19 immunization. The patient was vaccinated in other vaccination facility. Medical history included controlled high blood pressure and allergies to Asprin and Acetaminophen, all from an unknown date. Patient was not pregnant at the time of vaccination. Concomitant medications included calcium, diltiazem 280, lisinopril, and "AREDS." The patient received these medications within 2 weeks of vaccination. The patient was not diagnosed with COVID prior to vaccination, did not receive any other vaccines within 4 weeks prior to BNT162B2, and has not been tested for COVID post vaccination. The patient reported that the adverse events started on 17Jan2021. It's been two (2) weeks since her first vaccine, and the injection site is still slightly pink and itches several times a day. At first, she thought it was a bug bite. It was a little tender to touch. Outcome of the events was recovering. The events were reported as Non-serious.

Other Meds: CALCIUM; DILTIAZEM; LISINOPRIL

Current Illness:

ID: 1068046
Sex: F
Age:
State: CA

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: tired/very tired; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265, expiry date: unknown), via an unspecified route of administration on 28Jan2021 13:45 (at the age of 81 years old) at a single dose in the left arm for covid-19 immunisation. Medical history included obesity. The patient's concomitant medications were not reported. The patient is not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with covid-19 prior to vaccination and has not been tested for covid-19 since the vaccination. The patient had no known allergies. On 30Jan2021, the patient experienced tired and following day very tired from which she slept five hours during the day. The patient did not receive any treatment for the event. Outcome of the event was unknown. Event was reported as non-serious.

Other Meds:

Current Illness:

ID: 1068047
Sex: F
Age:
State: TX

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Couldn't take a full breath. Most intense standing or laying down, lesser when seated/when exercising like I can't take a big enough breathe; Centralized chest pain on sternum.; Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak; Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak; Arm soreness; Nauseous all week; loss of appetite; Sore to touch; heavy chested; medical history included Hashimoto's; medical history included Hashimoto's; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318; expiration date not provided), via an unspecified route of administration on 25Jan2021 19:00 at SINGLE DOSE for COVID-19 immunisation. Patient's medical history included Hashimoto's, asthma, and food allergy all from unknown dates and unknown if ongoing. The patient has no COVID prior vaccination. The patient was not COVID tested post vaccination. Patient is not pregnant. Concomitant medications included levothyroxine sodium, liothyronine sodium, progesteron, and sertraline. Adverse events on 26Jan2021 at 07:00 were reported as follows: Centralized chest pain on sternum. Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak (patient reported that she has asthma). Sore to touch. Couldn't take a full breath, most intense standing or laying down, lesser when seated. Lasted just over 48 hours. Patient also stated, 'Still feel heavy chested when exercising like I can't take a big enough breathe'. Patient also reported arm soreness, nauseous all week, loss of appetite. Also on period. The patient has not received treatment for the events. Outcome of the events was reported as 'Recovered with lasting effects'.

Other Meds: LEVOTHYROXINE SODIUM; LIOTHYRONINE SODIUM; PROGESTERON; SERTRALINE

Current Illness:

ID: 1068048
Sex: F
Age:
State: MI

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: lightheaded; tired; achy; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 22Jan2021 19:00 at a single dose for Covid-19 immunization. Medical history included borderline hypertension and allergies to latex. Patient was not pregnant. Concomitant medications included atorvastatin, lisinopril, and fish oil. The patient previously took morphine and had allergy. Patient reported that the day after the vaccination, she experienced lightheaded, tired, and achy at 2pm on 23Jan2021. She had these symptoms every day since. Some days it happens more often than others. It happens at different times such as lying down, walking, etc. No treatment was given. Outcome of the events was not recovered. Information regarding the lot/batch number has been requested.

Other Meds: ATORVASTATIN; LISINOPRIL; FISH OIL

Current Illness:

ID: 1068049
Sex: M
Age:
State: VA

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: 103 fever; Chills; horrible headache; This is a spontaneous report from a contactable consumer (patient). A 20-year-old male patient received first single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration (vaccine location: left arm) on 30Jan2021 15:45 for Covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: School or Student Health Clinic. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. On 31Jan2021, the patient experienced chills, horrible headache and 103 fever. The events were considered as non-serious by the reporter. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068050
Sex: F
Age:
State: IL

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Bad headache; pain at location of injection; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number E13302), via an unspecified route of administration (arm right) on 15Jan2021 11:30 SINGLE DOSE for covid-19 immunisation, at 42 years old. Medical history reported as none. The patient is not pregnant. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient has no reported allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI FE), therapy date and indication unknown (received withing 2 weeks). The patient experienced bad headache lasting over 24 hours, pain at location of injection for two days, and diarrhea on 15Jan2021 11:30. Treatment was not given. Outcome of the events was recovered on Jan2021. The reporter considered the events as non-serious.

Other Meds: BLISOVI FE

Current Illness:

ID: 1068051
Sex: F
Age:
State: CA

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: numbness and tingling in her neck - radiating to the pinnae of her ears, bilateral shoulders and to bilateral upper and lower extremities (BUE and BLE); felt acutely short of breath and anxious; felt acutely short of breath and anxious; numbness and tingling in her neck - radiating to the pinnae of her ears, bilateral shoulders and to bilateral upper and lower extremities (BUE and BLE); This is a spontaneous report from a contactable physician. A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 28Jan2021 16:00 (at the age of 47 years old) at a single dose for covid-19 immunization. Medical history included known allergies: shellfish, seasonal allergies and psoriasis. Concomitant medications included several medications in two weeks. The patient is not pregnant. The patient had no other vaccine in four weeks. On 29Jan2021 23:45, after being asleep for approximately one hour, felt acutely short of breath and anxious, which lasted less than a minute and was then followed by numbness and tingling in her neck - radiating to the pinnae of her ears, bilateral shoulders and to bilateral upper and lower extremities (BUE and BLE). These events resulted in emergency room visit. The patient underwent lab tests and procedures which included PCR/nasal swab on 29Jan2021 (post vaccination) which showed negative. Therapeutic measures were taken as a result of all the events which included diphenhydramine (BENADRYL), IVF. Outcome of all the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068052
Sex: F
Age:
State:

Vax Date: 01/27/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: right cervical and axillary lymphadenopathy; This is a spontaneous report received from a contactable nurse (who is also the patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261, expiry date: unknown), via an unspecified route of administration on the right arm, on 27Jan2021 13:15, at single dose, for COVID-19 immunization, at public health department. Medical history included hypertension (HTN), anxiety, depression, myalgia and penicillin allergy (PCN allergy). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. Concomitant medication included losartan; hydrochlorothiazide, triamterene (MAXZIDE); cetirizine; colecalciferol (VITAMIN D); escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2 vaccination. On 29Jan2021, the patient experienced right cervical and axillary lymphadenopathy. No treatment was given for the event. The patient was recovering from the event. The reporter assessed the event as non-serious.

Other Meds: LOSARTAN; MAXZIDE; CETIRIZINE; VITAMIN D; LEXAPRO

Current Illness:

ID: 1068053
Sex: F
Age:
State: KY

Vax Date: 01/24/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: headache; nausea; low grade temp/fever; body aches; chills; This is a spontaneous report from a contactable nurse (also the patient). A 33-year-old (also the age at vaccination) female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL8982), via an unspecified route of administration at the left arm on 24Jan2021 at SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. The patient first dose was given on 03Jan2021 02:00 PM at the left arm (lot: EL3246) for covid-19 immunization. The patient was vaccinated at a Public Health Department (also reported as Public Health Clinic/Administration facility). The patient is not pregnant. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included ethinylestradiol, norethisterone (VYFEMLA), collagen and unspecified multivitamin and anti-allergy (reported as received within 2 weeks of vaccination). It was reported that the patient experienced low grade temp, fever, body aches, chills on 25Jan2021 at 04:00 AM, then fever, headache, nausea on 26Jan2021 and also headache on 27Jan2021. No treatment was received for the adverse event. The outcome of the events was recovered in Jan2021. The case/ events were considered as non-serious

Other Meds: VYFEMLA; COLLAGEN

Current Illness:

ID: 1068054
Sex: F
Age:
State: MD

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Severe joint and muscle pain/persistent moderate joint pain; Severe joint and muscle pain; This is a spontaneous report from a contactable physician (patient). A 40-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL1283), intramuscular on 12Jan2021 08:30 at single dose (left arm) for COVID-19 immunization. The patient medical history was not reported. The patient had no chronic health conditions. The patient was not pregnant. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL), cetirizine hydrochloride (ZYRTEC), and ergocalciferol (VIT D). The patient previously took demerol and toradol and experienced allergies. The patient received first dose of bnt162b2 on 22Dec2020, 16:30 (left arm; lot EK5730) for COVID-19 immunization. On 12Jan2021, the patient experienced severe joint and muscle pain on first night of 2nd vaccine and joints most involved were both ankles, hips, and wrists and mostly resolved by 48 hours. Then, it returned on post-vaccine Day 5, on 17Jan2021, and had persistent moderate joint pain in both ankles, hips, and right wrist. patient had been taking Naproxen scheduled x10 days at regular dose with no improvement. Patient discussed it with her hospital's Chief of ID and started taking scheduled high dose Naproxen and requested referral to rheumatologist. The events resulted in doctor or other healthcare professional office/clinic visit. The patient had no other vaccine in four weeks, no covid prior vaccination and was not covid tested post vaccination. Outcome of events was not recovered.

Other Meds: JUNEL; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VIT D

Current Illness:

ID: 1068055
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: minor injection site soreness; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El324? (as reported)), via an unspecified route of administration at the left arm on 08Jan2021 at 13:00 (01:00 PM) at a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no medical history. The patient had no allergies to medications, food, or other products. Concomitant medication included levothyroxine sodium (UNITHROID) that was received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced minor injection site soreness on Jan2021. The event was reported as non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event was recovered on Jan2021.

Other Meds: UNITHROID

Current Illness:

ID: 1068056
Sex: F
Age:
State: OR

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: chills; fatigue; migraine-like headaches; dizziness; nausea; migraine-like headache and fatigue severe enough to prevent normal activity; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), intramuscularly into the left arm on 28Jan2021 14:15 at a single dose for COVID-19 immunisation. Medical history included Polycystic ovarian syndrome (PCOS), depression, obesity and allergies to latex. Patient was not pregnant. Concomitant medication included duloxetine hydrochloride (CYMBALTA), bupropion hydrochloride (WELLBUTRIN), colecalciferol (VITAMIN D) and cyanocobalamin (VITAMIN B12). The patient previously took tetracycline and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685), intramuscularly into the right arm on 06Jan2021 03:15 PM at a single dose for COVID-19 immunisation. On 28Jan2021 20:00, patient experienced chills, fatigue, migraine-like headaches, dizziness, nausea and migraine-like headache and fatigue severe enough to prevent normal activity. The events were reported as non-serious. The patient did not receive any treatment for the events reported. Outcome of events was unknown.

Other Meds: CYMBALTA; WELLBUTRIN; VITAMIN D; VITAMIN B12

Current Illness:

ID: 1068057
Sex: F
Age:
State: NY

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Hives; This is a spontaneous report from a non-contactable consumer (patient). A 48-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9262), via an unspecified route of administration on 28Jan2021 at a single dose on the right arm for COVID-19 immunization. Medical history included asthma and postpartum cardiomyopathy on unknown dates and unknown if ongoing. The patient had allergies to sulfa and penicillin. Prior to vaccination, the patient has not had COVID-19. Concomitant medication included fexofenadine hydrochloride (ALLEGRA), carvedilol (manufacturer unknown), cefixime (FLEXERIL), losartan (manufacturer unknown) and montelukast sodium (SINGULAIR). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took Cipro, Biaxin and Ampicillin and allergies. Since the vaccination, the patient has not been tested for COVID. The patient experienced hives on 30Jan2021. The patient did not receive any treatment for the event. The patient has not recovered from the event. No follow-up attempts are possible. No further information is expected.

Other Meds: ALLEGRA; CARVEDILOL; FLEXERIL [CEFIXIME]; LOSARTAN; SINGULAIR

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm